According to the business intelligence report titled ‘Global Clinical Trials Market 2022-2028’, available with MarketStudyReport, global clinical trials market is estimated to record a compound annual growth rate of 5.3% through 2028 and amass a valuation of USD 52,794 million by the end of analysis timeframe.

As per report findings, demand for developing new & effective medications, favorable regulatory landscape, and rising emphasis on novel treatment procedures are the key factors aiding the augmentation in global clinical trials market growth.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042715/  

In addition, technological advancements in the healthcare sector, coupled with the availability of skilled medical practitioners are likely to widen the expanse of the market in the forthcoming years.

For those unaware, clinical trials refer to a kind of research wherein people volunteer and take part in testing medical interventions such as drugs, behavioral treatments, radiological, and surgical procedures along with preventive care methodologies to evaluate their effect on human health.

Apart from growth drivers and opportunities, the research literature also sheds light on major challenges that may hamper the growth trajectory of the industry during the forecast period, while providing key insights into solutions that aid in mitigating the impact.

For the sake of a comprehensive assessment, worldwide clinical trials industry space is classified in terms of phase (phase 1, phase 2, phase 3, phase 4), indication type (obesity, autoimmune, diabetes, pain management, cardiovascular, oncology, CNS condition, others), and geographical expanse (North America, Europe, Asia Pacific, South America, Middle East & Africa). Each regional market is summarized effectively, with focus on pivotal parameters such as revenue share, current trends, consumption statistics, and scope for expansion, thereby enabling stakeholders to identify major avenues for remuneration during the forecast duration. Each regional market is summarized effectively, shedding lightwith focus on pivotal parameters such as market size, revenue share, current trends, consumption statistics, and scope for expansion, thereby enabling stakeholders to identify major avenues for amplifying their remuneration during the forecast duration.

Considering the competitive framework, Pfizer Inc., ICON plc, Eli Lilly and Company, IQVIA Holdings Inc., F. Hoffmann-La Roche AG, Parexel International Corporation, Laboratory Corporation of America Holdings, Novo Nordisk A/S, Sanofi S.A., Wuxi AppTec Co. Ltd., Pharmaceutical Product Development Inc., Syneos Health Inc., Clinipace Clinical Research Pvt. Ltd., and Charles River Laboratories International Inc. are the major players influencing global clinical trials market trends.